Anti-Human/Mouse BMP5 Antibody with collaborator-tested evidence for WB.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Human/Mouse BMP5 Antibody is a research-use antibody from Elabscience for studying BMP5 in WB workflows with listed reactivity for Human, Mouse. Specifications and supporting documents below should be reviewed when planning the experiment.
Fully tested in-house by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP |
|---|---|---|---|---|---|---|---|
| Human | |||||||
| Mouse |
This product is manufactured by Elabscience and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
BMP5 (bone morphogenetic protein 5) is a secreted TGF-beta-superfamily ligand that activates bone morphogenetic protein receptor signalling and is studied in skeletal, bone and cartilage development.
Biological function: BMP5 is synthesized as a precursor that is processed to a secreted mature ligand of the TGF-beta superfamily. It signals through BMP receptor serine/threonine kinases to activate downstream SMAD pathways, supporting developmental programmes that include bone and cartilage formation.
